ANDREA MCCOY: Open Payments
NPI 1053032482 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,000 in 83 payments from 20 companies in 2025. Trend: 2023 $1,689 · 2024 $1,972 · 2025 $2,000
Food & beverage: $1,719Travel & lodging: $281
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 12 | $696 |
| Xeris Pharmaceuticals, Inc. | 13 | $233 |
| Corcept Therapeutics | 16 | $230 |
| Lilly USA, LLC | 11 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $103 |
| Madrigal Pharmaceuticals | 1 | $95 |
| Novo Nordisk Inc | 4 | $81 |
| BETA BIONICS, INC. | 3 | $71 |
| Mannkind Corporation | 3 | $63 |
| Tandem Diabetes Care, Inc. | 2 | $36 |
Products named: MINIMED 780G, Korlym, RECORLEV, MOUNJARO, Kerendia, REZDIFFRA, iLet Bionic Pancreas, AFREZZA.
Industry payments across TX — which companies pay providers there.
